Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

ORS (Oral Rehydration Salts) effervescent tablet

This ORS effervescent tablet has been developed according to the latest guidelines of the WHO. We are looking for partners in Europe and in other areas to commercialize the ORS effervescent tablets

Mechanism of action

The ORS effervescent tablet has been developed and very recently introduced in the Netherlands, a marketshare of 15% was accomplished within the first 3 month's.

Full description

We developed an ORS (Oral Rehydration Salts) effervescent tablet. The normal dosage form is in sachet. Some of the major advantages of the effervescent tablets are:
•    Desintegration time (< 1 minute) in glass of water
•    Completely dissolves, no remaining residues
•    Fress lemon flavour
•    This dosage form much more appreciated than sachet
•    More attractive price structure
•    Unique dosage form
•    Developed according the latest guidelines of the WHO

Development status

Registered

Type of business relationship sought

We are looking for partnerships to commercialize the ORS effervescent tablets in Europe and other territories.

Licensing contact

Albert de Bruin
Request more information

Company details

Focus Care Pharmaceuticals B.V
Focus Care commercialize added value brands, generics and OTC products

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Pharmaceutical Strategic Alliances
Stem Cell Conference
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us